Page last updated: 2024-08-16

salmeterol xinafoate and Allergic Reaction

salmeterol xinafoate has been researched along with Allergic Reaction in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bender, BG1
Jansen, HM; Koopmans, JG; Lutter, R; van der Zee, JS1
Aaronson, DW1
Chipps, B1
Brogden, RN; Faulds, D1
Butchers, PR; Johnson, M; Vardey, CJ1

Reviews

2 review(s) available for salmeterol xinafoate and Allergic Reaction

ArticleYear
Where does health communication technology fit into allergy practice?
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 121, Issue:1

    Topics: Anti-Allergic Agents; Biosensing Techniques; Confidentiality; Exhalation; Fluticasone; Health Communication; Humans; Hypersensitivity; Medical Informatics; Monitoring, Physiologic; Nitric Oxide; Patient Compliance; Salmeterol Xinafoate; Self-Management; Smartphone; Spirometry

2018
Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchoconstriction; Humans; Hypersensitivity; Salmeterol Xinafoate

1991

Trials

2 trial(s) available for salmeterol xinafoate and Allergic Reaction

ArticleYear
Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    The Journal of allergy and clinical immunology, 2005, Volume: 116, Issue:5

    Topics: Administration, Inhalation; Albuterol; Allergens; Androstadienes; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Eosinophils; Fluticasone; Humans; Hypersensitivity; Interleukin-5; Leukocyte Count; Salmeterol Xinafoate; Time Factors

2005
Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchoconstriction; Humans; Hypersensitivity; Salmeterol Xinafoate

1991

Other Studies

4 other study(ies) available for salmeterol xinafoate and Allergic Reaction

ArticleYear
The "black box" warning and allergy drugs.
    The Journal of allergy and clinical immunology, 2006, Volume: 117, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Calcineurin Inhibitors; Drug Labeling; Ethanolamines; Formoterol Fumarate; Humans; Hypersensitivity; Immunosuppressive Agents; Informed Consent; Salmeterol Xinafoate; United States; United States Food and Drug Administration

2006
Systemic reaction to omalizumab.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:2

    Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope

2006
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 84, Issue:5

    Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine

2000
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
    British journal of pharmacology, 1991, Volume: 104, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Histamine Release; Humans; Hypersensitivity; In Vitro Techniques; Inflammation; Lung; Mast Cells; Propranolol; Prostaglandin D2; Salmeterol Xinafoate; SRS-A

1991